RA CAPITAL MANAGEMENT, L.P.

13D and 13G Filings

Investors who own more than 5% of a class must file a Schedule 13D or 13G. The latest filing for each security since 12/18/2024, newest first.

Issuer	Symbol	CUSIP	% of Class	Shares	Form	Filed
Vor Biopharma Inc. 13D/A VOR · 929033108	VOR	929033108	31.8%	39,739,850	13D/A	6/27/2025 Event 6/25/2025
RA Capital Management, L.P.			31.8%	39,739,850
Peter Kolchinsky			31.8%	39,739,850
Rajeev Shah			31.8%	39,739,850
RA Capital Healthcare Fund, L.P.			30.3%	37,820,713
Iteos Therapeutics, Inc. 13D/A ITOS · 46565G104	ITOS	46565G104	4.9%	2,134,806	13D/A	5/19/2025 Event 5/15/2025
RA Capital Management, L.P.			4.9%	2,134,806
Peter Kolchinsky			4.9%	2,134,806
Rajeev Shah			4.9%	2,134,806
RA Capital Healthcare Fund, L.P.			4.4%	1,896,784
Kura Oncology, Inc. 13G/A KURA · 50127T109	KURA	50127T109	4.9%	4,004,610	13G/A	5/15/2025 Event 3/31/2025
RA Capital Management, L.P.			4.9%	4,004,610
Peter Kolchinsky			4.9%	4,004,610
Rajeev Shah			4.9%	4,004,610
RA Capital Healthcare Fund, L.P.			4.9%	4,004,610
Newamsterdam Pharma Company N.V. 13G/A NAMS · N62509109	NAMS	N62509109	9.9%	11,063,125	13G/A	5/15/2025 Event 3/31/2025
RA Capital Management, L.P.			9.9%	11,063,125
Peter Kolchinsky			9.9%	11,063,125
Rajeev Shah			9.9%	11,063,125
RA Capital Healthcare Fund, L.P.			9.9%	11,063,125
Unicycive Therapeutics, Inc. 13G/A UNCY · 90466Y103	UNCY	90466Y103	9.9%	13,285,781	13G/A	5/15/2025 Event 3/31/2025
RA Capital Management, L.P.			9.9%	13,285,781
Peter Kolchinsky			9.9%	13,285,781
Rajeev Shah			9.9%	13,285,781
RA Capital Healthcare Fund, L.P.			9.9%	13,285,781
Chimerix Inc 13G/A CMRX · 16934W106	CMRX	16934W106	0%	0	13G/A	5/15/2025 Event 3/31/2025
RA Capital Management, L.P.			0%	0
Peter Kolchinsky			0%	0
Rajeev Shah			0%	0
RA Capital Healthcare Fund, L.P.			0%	0
Bright Minds Biosciences Inc. 13G/A DRUG · 10919W405	DRUG	10919W405	2.9%	206,427	13G/A	5/15/2025 Event 3/31/2025
RA Capital Management, L.P.			2.9%	206,427
Peter Kolchinsky			2.9%	206,427
Rajeev Shah			2.9%	206,427
RA Capital Healthcare Fund, L.P.			2.9%	206,427
Janux Therapeutics, Inc. 13D/A JANX · 47103J105	JANX	47103J105	19.9%	11,971,377	13D/A	3/10/2025 Event 3/6/2025
RA Capital Management, L.P.			19.9%	11,971,377
Peter Kolchinsky			19.9%	11,971,377
Rajeev Shah			19.9%	11,971,377
RA Capital Healthcare Fund, L.P.			18.2%	10,861,013
Solid Biosciences Inc. 13D/A SLDB · 83422E105	SLDB	83422E105	9.9%	7,989,820	13D/A	2/21/2025 Event 2/19/2025
RA Capital Management, L.P.			9.9%	7,989,820
Peter Kolchinsky			9.9%	7,989,820
Rajeev Shah			9.9%	7,989,820
RA Capital Healthcare Fund, L.P.			9.8%	7,823,558
Tenaya Therapeutics, Inc. 13G/A TNYA · 87990A106	TNYA	87990A106	0%	0	13G/A	2/14/2025 Event 12/31/2024
RA Capital Management, L.P.			0%	0
Peter Kolchinsky			0%	0
Rajeev Shah			0%	0
RA Capital Healthcare Fund, L.P.			0%	0
Recursion Pharmaceuticals, Inc. 13G/A RXRX · 75629V104	RXRX	75629V104	2.0%	7,725,096	13G/A	2/14/2025 Event 12/31/2024
RA Capital Management, L.P.			2.0%	7,725,096
Peter Kolchinsky			2.0%	7,725,096
Rajeev Shah			2.0%	7,725,096
RA Capital Healthcare Fund, L.P.			2.0%	7,725,096
Macrogenics, Inc. 13G/A MGNX · 556099109	MGNX	556099109	0%	0	13G/A	2/14/2025 Event 12/31/2024
RA Capital Management, L.P.			0%	0
Peter Kolchinsky			0%	0
Rajeev Shah			0%	0
RA Capital Healthcare Fund, L.P.			0%	0
Longboard Pharmaceuticals, Inc. 13G/A LBPH · 54300N103	LBPH	54300N103	0%	0	13G/A	2/14/2025 Event 12/31/2024
RA Capital Management, L.P.			0%	0
Peter Kolchinsky			0%	0
Rajeev Shah			0%	0
RA Capital Healthcare Fund, L.P.			0%	0
GlycoMimetics, Inc. 13G/A GLYC · 38000Q102	GLYC	38000Q102	0%	0	13G/A	2/14/2025 Event 12/31/2024
RA Capital Management, L.P.			0%	0
Peter Kolchinsky			0%	0
Rajeev Shah			0%	0
RA Capital Healthcare Fund, L.P.			0%	0
EyePoint Pharmaceuticals, Inc. 13G/A EYPT · 30233G209	EYPT	30233G209	4.7%	3,181,818	13G/A	2/14/2025 Event 12/31/2024
RA Capital Management, L.P.			4.7%	3,181,818
Peter Kolchinsky			4.7%	3,181,818
Rajeev Shah			4.7%	3,181,818
RA Capital Healthcare Fund, L.P.			4.7%	3,181,818
Evolent Health, Inc. 13G/A EVH · 30050B101	EVH	30050B101	3.1%	3,577,197	13G/A	2/14/2025 Event 12/31/2024
RA Capital Management, L.P.			3.1%	3,577,197
Peter Kolchinsky			3.1%	3,577,197
Rajeev Shah			3.1%	3,577,197
RA Capital Healthcare Fund, L.P.			3.1%	3,577,197
Ensysce Biosciences, Inc. 13G/A ENSC · 293602405	ENSC	293602405	0%	0	13G/A	2/14/2025 Event 12/31/2024
RA Capital Management, L.P.			0%	0
Peter Kolchinsky			0%	0
Rajeev Shah			0%	0
RA Capital Healthcare Fund, L.P.			0%	0
Cytek Biosciences, Inc. 13G/A CTKB · 23285D109	CTKB	23285D109	0%	0	13G/A	2/14/2025 Event 12/31/2024
RA Capital Management, L.P.			0%	0
Peter Kolchinsky			0%	0
Rajeev Shah			0%	0
RA Capital Healthcare Fund, L.P.			0%	0
Cybin Inc. 13G/A CYBN · 23256X100	CYBN	23256X100	0%	0	13G/A	2/14/2025 Event 12/31/2024
RA Capital Management, L.P.			0%	0
Peter Kolchinsky			0%	0
Rajeev Shah			0%	0
RA Capital Healthcare Fund, L.P.			0%	0
Bioage Labs, Inc. 13G/A BIOA · 09077V100	BIOA	09077V100	3.7%	1,310,589	13G/A	2/14/2025 Event 12/31/2024
RA Capital Management, L.P.			3.7%	1,310,589
Peter Kolchinsky			3.7%	1,310,589
Rajeev Shah			3.7%	1,310,589
RA Capital Healthcare Fund, L.P.			2.7%	982,942
AN2 Therapeutics, Inc. 13G/A ANTX · 037326105	ANTX	037326105	0%	0	13G/A	2/14/2025 Event 12/31/2024
RA Capital Management, L.P.			0%	0
Peter Kolchinsky			0%	0
Rajeev Shah			0%	0
RA Capital Healthcare Fund, L.P.			0%	0
Alto Neuroscience, Inc. 13G/A ANRO · 02157Q109	ANRO	02157Q109	0%	0	13G/A	2/14/2025 Event 12/31/2024
RA Capital Management, L.P.			0%	0
Peter Kolchinsky			0%	0
Rajeev Shah			0%	0
RA Capital Healthcare Fund, L.P.			0%	0
Zura Bio Limited 13G/A ZURA · G9TY5A101	ZURA	G9TY5A101	4.9%	3,217,503	13G/A	2/14/2025 Event 12/31/2024
RA Capital Management, L.P.			4.9%	3,217,503
Peter Kolchinsky			4.9%	3,217,503
Rajeev Shah			4.9%	3,217,503
RA Capital Healthcare Fund, L.P.			4.9%	3,217,503